Welcome!

To use the personalized features of this site, please log in or register.

If you have forgotten your username or password, we can help.

Journal Article Printable view
A Rare Case of Primary Ovarian Lymphoma in Patients With Rheumatoid Arthritis: Can We Attribute This to Tumor Necrosis Factor Inhibitors?

A Rare Case of Primary Ovarian Lymphoma in Patients With Rheumatoid Arthritis: Can We Attribute This to Tumor Necrosis Factor Inhibitors?

JournalClinical Ovarian Cancer
PublisherCIG Media Group, L.P.
ISSN1941-4390 (Print)
1941-4404 (Online)
SubjectCancer and Oncology, Clinical Medicine, Case Studies, Cancer Research, Gynecology, Radiotherapy, Imaging and Radiology
IssueVolume 2, Number 2 / November 2009
CategoryCase Report
Pages121-123
DOI10.3816/COC.2009.n.020
Online DateTuesday, December 01, 2009


Export this chapter
 
advertisment
Authors
Swapna Thota1, Sudhir Manda2, Mazen Dahbar1, Hameed Daw3

1 Cleveland Clinic Cancer Center, Fairview Hospital, Cleveland, OH
2Department of Medicine, Cleveland Clinic Foundation, Cleveland, OH
3Department of Hematology/Oncology, Cleveland Clinic Cancer Center, Fairview Hospital, Cleveland, OH

Abstract

Ovarian involvement as an initial manifestation of lymphoma is a rare occurrence. A literature search reveals that the current knowledge is limited to few case reports. Recently it has been suggested that the use of tumor necrosis factor inhibitors (TNFIs) is associated with increased incidence of malignant lymphomas. Herein, we present a case of primary ovarian lymphoma in a patient with severe rheumatoid arthritis receiving long-term treatment with TNFIs.

Preview first page of full text.
Keywords
CA-125, CD20, Non-Hodgkin lymphoma, Non-Hodgkin's lymphoma, Pelvic pain
Fulltext Preview (Small, Large)
Image of the first page of the fulltext

Show References